News
Latest Insights
Latest Updates and Conferences
DirectSens’ Market-Leading LactoSens® BioSensor Technology acquired by Kerry Group P.L.C.
VIENNA. Austria – October 29, 2024 — DirectSens, a pioneer in next generation biosensor technology, announces the acquisition of its LactoSens® technology by Kerry Group, a global leader in taste and nutrition. The acquisition of LactoSens® reflects DirectSens’ success in developing cutting-edge biosensor solutions and represents a move by Kerry
A Breakthrough for Women’s Health: DirectSens Launches XpressGT to Combat Gestational Diabetes and More
XpressGT provides accurate measurement of levels of 2-hydroxybutyrate (2-HB) found in venous blood.
Meet us at AnugaFoodTec
Get ready to dive into the heart of innovation with us at Anuga FoodTec — the ultimate industry rendezvous for cutting-edge advancements.
Technology
End-to-End Biosensor Solutions
End-to-End Biosensor Solutions with Advanced Enzyme Technology At DirectSens, a full end-to-end solution for biosensor manufacturing is applied, where the entire process—from enzyme discovery to large-scale production—remains in-house. Advanced fermentation technology and bioinformatics are applied to optimize enzymes for modern sensor architectures. Enzyme production is scaled through precision fermentation to
Next Generation Biosensor Technology
The DirectSens Story DirectSens, an Austrian biotechnology company, has been at the forefront of biosensor innovation since its founding in 2013. Established with the mission of translating scientific research into practical solutions, DirectSens specializes in developing next-generation biosensors, focusing on creating enzymes tailored for specific applications. The company successfully launched
The core of every biosensor is an enzyme
Why enzyms play a curcial role in biosensors Biosensors are powerful analytical devices that detect and measure specific analytes, revolutionizing fields like healthcare and environmental monitoring. Since the first commercial biosensor was introduced in the 1970s, these devices have saved millions of lives (Clark et al., 1962). However, the enzymes
Products
DirectSens’ Market-Leading LactoSens® BioSensor Technology acquired by Kerry Group P.L.C.
VIENNA. Austria – October 29, 2024 — DirectSens, a pioneer in next generation biosensor technology, announces the acquisition of its LactoSens® technology by Kerry Group, a global leader in taste and nutrition. The acquisition of LactoSens® reflects DirectSens’ success in developing cutting-edge biosensor solutions and represents a move by Kerry
A Breakthrough for Women’s Health: DirectSens Launches XpressGT to Combat Gestational Diabetes and More
XpressGT provides accurate measurement of levels of 2-hydroxybutyrate (2-HB) found in venous blood.
DRRR proficiency testing confirmed excellent performance of LactoSens®R
DRRR proficiency testing confirmed excellent performance of LactoSens®R Accuracy, precision and reliability are the key success factors of LactoSens®. The latest DRRR proficiency testing confirmed this claim, again! We are periodically challenging LactoSens® in external proficiency tests (see Independent proficiency testing showed excellent results for LactoSens® for more results). In the latest DRRR proficiency test two UHT